Cargando…

Lack of association of statin use with vitamin D levels in a hospital based population of type 2 diabetes mellitus patients

OBJECTIVE: To investigate the relationship of statins (drug given to reduce serum levels of LDL-cholesterol) on vitamin D levels of Pakistani type 2 diabetes mellitus (DM) patients in a hospital in Karachi. METHODS: In a cross-sectional survey, 312 consecutive patients with type 2 DM (219 males and...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Khalida, Islam, Najmul, Azam, Iqbal, Mehboobali, Naseema, Iqbal, Mohammad Perwaiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857014/
https://www.ncbi.nlm.nih.gov/pubmed/29643908
http://dx.doi.org/10.12669/pjms.341.11977
Descripción
Sumario:OBJECTIVE: To investigate the relationship of statins (drug given to reduce serum levels of LDL-cholesterol) on vitamin D levels of Pakistani type 2 diabetes mellitus (DM) patients in a hospital in Karachi. METHODS: In a cross-sectional survey, 312 consecutive patients with type 2 DM (219 males and 93 females, age 22-70 years) were recruited with informed consent. A questionnaire was administered to find out whether they were statin users or non-users. Serum was analyzed for concentrations of 25(OH) vitamin D [25(OH)D] and other related biomarkers such as serum cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, phosphate and calcium using kit methods. Multiple Linear Regression was used to evaluate association of statin use with serum levels of vitamin D while adjusting for related covariates including duration of statin use, duration of type 2 DM and smoking. RESULTS: Mean concentrations of serum cholesterol, and LDL-cholesterol were lower among statin users compared to statin non-users (P < 0.01), while HDL-cholesterol levels were higher (P<0.01). No relationship was observed between statin use and serum levels of vitamin D (P=0.768), when adjusted for age, gender, BMI, duration of type 2 DM, smoking, serum cholesterol and LDL-cholesterol. The adjusted regression coefficient (β) and standard error [SE(β)] for statin use duration were 0.012 (0.042), when serum levels of vitamin D was taken as an outcome. CONCLUSION: Lack of association was found between statin use and vitamin D levels in a hospital-based population of Pakistani patients with type 2 DM.